Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Consensus Recommendation of "Buy" from Brokerages

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) have been assigned an average rating of "Buy" from the four ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and two have issued a strong buy rating on the company.

A number of equities research analysts have recently weighed in on CRLBF shares. Cormark raised Cresco Labs from a "hold" rating to a "moderate buy" rating in a research note on Monday, March 17th. Canaccord Genuity Group cut Cresco Labs from a "strong-buy" rating to a "moderate buy" rating in a research note on Tuesday.

Cresco Labs Price Performance

OTCMKTS:CRLBF opened at $0.53 on Friday. Cresco Labs has a 52 week low of $0.49 and a 52 week high of $2.05. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The company has a market capitalization of $260.24 million, a P/E ratio of -2.65 and a beta of 1.73. The stock's fifty day moving average is $0.69 and its two-hundred day moving average is $0.84.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last posted its earnings results on Friday, May 30th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.01). Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. The business had revenue of $165.76 million during the quarter, compared to analysts' expectations of $164.37 million. Equities analysts expect that Cresco Labs will post -0.2 EPS for the current year.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.